Nikkei Upbeat on Cautious BoJ Hold
Unlike the last decision that had caused the stock market to plunge, today's cautious pause by the Japanese central bank, saw muted JPN225 reaction and weekly gains
Page 2 of 44
Unlike the last decision that had caused the stock market to plunge, today's cautious pause by the Japanese central bank, saw muted JPN225 reaction and weekly gains
Tech optimism returned after Nvidia CEO offered upbeat AI message, helping NAS100 looks past upside surprise in core CPI
The tech-heavy index posted its worst week of the year and re-entered correction territory after a negative reaction to the NFPs, as markets await Wednesday’s inflation update
Yesterday, the S&P 500 fell for a third consecutive session as markets await today's key August jobs report, which could influence the Federal Reserve’s upcoming interest rate decision. Broadcom’s disappointing revenue guidance and concerns over the AI rally added to market jitters.
The tech-heavy index is on the verge of correction, as Nvidia suffered heavy losses and weak PMIs reignite recession fears, ahead of Friday’s jobs report
Biotech stocks are showing signs of recovery, supported by expected rate cuts and bullish technical indicators. The sector's improving fundamentals could provide a strong boost to the broader healthcare market.
After a strong performance last month, HKG33 starts September with a fall to critical tech levels as manufacturing PMI contracted further
Despite the AI bellwether's blockbuster results, guidance created concerns, but NAS100 regains its footing as markets focus on Fed rate cut prospects
The revenue surge of Xiaomi partly due to the successful EV entry provides support to HKG33 and helps it look overcome the Walmart JD stake sale, but technical hurdles loom
HKG33 rebounded after the poor weekly start, but trades with caution ahead of key resistance cluster, despite an acceleration in Chinese inflation
The Japanese index unraveled due to the BoJ rate hike and Yen rebound, but stages a rebound helped by dovish comments from BoJ officials
Any opinions, news, research, analyses, prices, other information, or links to third-party sites contained on this website are provided on an "as-is" basis, as general market commentary and do not constitute investment advice. The market commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is therefore not subject to any prohibition on dealing ahead of dissemination. Although this commentary is not produced by an independent source, FXCM takes all sufficient steps to eliminate or prevent any conflicts of interests arising out of the production and dissemination of this communication. The employees of FXCM commit to acting in the clients' best interests and represent their views without misleading, deceiving, or otherwise impairing the clients' ability to make informed investment decisions. For more information about the FXCM's internal organizational and administrative arrangements for the prevention of conflicts, please refer to the Firms' Managing Conflicts Policy. Please ensure that you read and understand our Full Disclaimer and Liability provision concerning the foregoing Information, which can be accessed here.